J07BC02 • inactivated hepatitis A vaccine • Antiinfectives for systemic use | Viral vaccines | Hepatitis vaccines
The inactivated hepatitis A vaccine is used to prevent infection with the hepatitis A virus (HAV), which can cause acute hepatitis, an inflammatory liver disease. The vaccine contains inactivated hepatitis A viruses, which stimulate the immune system to produce specific antibodies against HAV.
The vaccine is administered intramuscularly, usually in two doses, 6-12 months apart. It is recommended for individuals traveling to endemic areas, children, food industry workers, and others at increased risk of infection.
Common side effects include pain at the injection site, mild fever, fatigue, and nausea. In rare cases, severe allergic reactions may occur.
The inactivated hepatitis A vaccine is an important preventive measure for reducing the risk of HAV infection and its associated complications, contributing to public health protection.
Substance: inactivated hepatitis A vaccine
Date of last drug list: 01-07-2014
Commercial code: W60610001
Concentration: 25 U / 0.5ml
Pharmaceutical form: injection suspension
Quantity: 1
Product type: original
Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).